The association between insomnia and cardiovascular diseases

Nature and Science of Sleep

Volumn 2, Issue , 2010, Pages 71-78

  Spiegelhalder, Kai ^a   Scholtes, Cathy ^a   Riemann, Dieter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cardiovascular mortality; Heart rate; Heart rate variability; Hypertension

Indexed keywords

EID: 80053903913     PISSN: None     EISSN: 11791608     Source Type: Journal    
DOI: 10.2147/nss.s7471     Document Type: Review

References (57)

1. American Academy of Sleep Medicine. The International Classification of Sleep Disorders, (ICSD-2): Diagnostic and Coding Manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.
2. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97-111. (Pubitemid 35231066)
3. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders - A meta-analysis. Arch Gen Psychiat. 1992;49(8): 651-668.
4. Riksen NP, Rongen GA, Smits P. Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol Ther. 2009;121(2):185-191.
5. Edinger JD, Bonnet MH, Bootzin RR, et al. Derivation of research diagnostic criteria for insomnia: report of an American academy of sleep medicine work group. Sleep. 2004;27(8):1567-1596. (Pubitemid 40041627)
6. Zhang B, Wing YK. Sex differences in insomnia: a meta-analysis. Sleep. 2006;29(1):21-22.
7. Riemann D, Voderholzer U. Primary insomnia: a risk factor to develop depression? J Affect Disord. 2003;76(1-3):255-259. (Pubitemid 37013378)
8. Schwartz S, McDowell Anderson W, Cole SR, Cornoni-Huntley J, Hays JC, Blazer D. Insomnia and heart disease: a review of epidemiologic studies. J Psychosom Res. 1999;47(4):313-333.
9. Wulsin L, Vaillant G, Wells V. A systematic review of the mortality of depression. Psychosom Med. 1999;61(1):6-17. (Pubitemid 29071841)
10. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99(16):2192-2217. (Pubitemid 29196806)
11. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA. 1993;270(15): 1819-1825. (Pubitemid 23301435)
12. Whooley MA, de Jonge P, Vittinghoff E. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300(20):2379-2388.
13. Schwartz SW, Cornoni-Huntley J, Cole SR, Hays JC, Blazer DG, Schocken DD. Are sleep complaints an independent risk factor for myocardial infarction? Ann Epidemiol. 1998;8(6):384-392. (Pubitemid 28340539)
14. Nilsson PM, Nilsson JA, Hedblad B, Berglund G. Sleep disturbance in association with elevated pulse rate for prediction of mortality-consequences of mental strain? J Intern Med. 2001;250(6): 521-529. (Pubitemid 34013511)
15. Mallon L, Broman JE, Hetta J. Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J Intern Med. 2002;251(3):207-216. (Pubitemid 34227184)
16. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59(2):131-136. (Pubitemid 34137380)
17. Phillips B, Mannino MD. Does insomnia kill? Sleep. 2005;28(8): 965-971. (Pubitemid 41170931)
18. Kripke DF, Klauber MR, Wingard DL, Fell RL, Assmus JD, Garfinkel L. Mortality hazard associated with prescription hypnotics. Biol Psychiatry. 1998;43(9):687-693. (Pubitemid 28222390)
19. Schulz R, Beach SR, Ives DG, Martire LM, Ariyo AA, Kop WJ. Association between depression and mortality in older adults: the Cardiovascular Health Study. Arch Intern Med. 2000;160(12):1761-1768. (Pubitemid 30418812)
20. Riemann D, Spiegelhalder K, Feige B, et al. The hyperarousal model of insomnia: A review of the concept and its evidence. Sleep Med Rev. 2010;14(1):19-31.
21. Perlis ML, Giles DE, Mendelson WB, Bootzin RR, Wyatt JK. Psychophysiological insomnia: the behavioral model and a neurocognitive perspective. J Sleep Res. 1997;6(3):179-188. (Pubitemid 27414458)
22. Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health. 2003;45(6): 344-350. (Pubitemid 38036189)
23. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47(5): 833-839. (Pubitemid 44297552)
24. Phillips B, Mannino DM. Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med. 2007;3(5):489-494. (Pubitemid 47378252)
25. Phillips B, Buzkova P, Enright P. Insomnia did not predict incident hypertension in older adults in the Cardiovascular Health Study. Sleep. 2009;32(1):65-72.
26. Vgontaz AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for Hypertension. Sleep. 2009;32(4):491-497.
27. Lanfranchi PA, Pennestri MH, Fradette L, Dumont M, Morin CM, Montplaisir J. Night time blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk. Sleep. 2009;32(6):760-766.
28. Fox K, Borer, JS, Camm AJ, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007;50(9):823-830. (Pubitemid 47277500)
29. Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol. 2008;51(18):1725-1733. (Pubitemid 351608496)
30. Haynes SN, Adams A, Franzen M. The effects of presleep stress on sleep-onset insomnia. J Abnorm Psychol. 1981;90(6):601-606.
31. Bonnet MH, Arand DL. Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med. 1998;60(5):610-615. (Pubitemid 28453026)
32. Monroe LJ. Psychological and physiological differences between good and poor sleepers. J Abnorm Psychol. 1967;72(3):255-264.
33. Freedman RR, Sattler HL. Physiological and psychological factors in sleep-onset insomnia. J Abnorm Psychol. 1982;91(5):380-389.
34. Varkevisser M, Van Dongen HP, Kerkhof GA. Physiologic indexes in chronic insomnia during a constant routine: evidence for general hyperarousal? Sleep. 2005;28(12):1588-1596. (Pubitemid 41747087)
35. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981;213(4504):220-222. (Pubitemid 11060568)
36. Malik M. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability standards of measurement, physiological interpretation, and clinical use. Eur Heart J. 1996;17(3):354-381.
37. Jurysta F, Lanquart JP, Sputaels V, et al. The impact of chronic primary insomnia on the heart rate-EEG variability link. Clin Neurophysiol. 2009;120(6):1054-1060.
38. Fang SC, Huang CJ, Yang TT, Tsai PS. Heart rate variability and daytime functioning in insomniacs and normal sleepers: preliminary results. J Psychosom Res. 2008;65(1):23-30.
39. Feige B, Al-Shajlawi A, Nissen C, et al. Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients. J Sleep Res. 2008;17(2):180-190. (Pubitemid 351678607)
40. Kripke DF, Simons RN, Garfinkel L, Hammond EC. Long-term use of sleeping pills is associated with a survival risk. Arch Gen Psychiatry. 1979;36(1):103-116. (Pubitemid 10187555)
41. Mallon L, Broman JE, Hetta J. Is usage of hypnotics associated with mortality? Sleep Med. 2009;10(3):279-286.
42. Kripke DF. Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry. 2007;7:42.
43. Neutel CI, Patten SB. Risk of suicide attempts after benzodiazepine and/or antidepressant use. Ann Epidemiol. 1997;7(8):568-574. (Pubitemid 27524370)
44. Kripke DF. Possibility that certain hypnotics might cause cancer in skin. J Sleep Res. 2008;17(3):245-250.
45. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep. 2003;26(7):793-799. (Pubitemid 39610622)
46. Ancoli-Israel S, Richardson GS, Mangano RM, Jenkins L, Hall P, Jones WS. Long-term use of sedative hypnotics in older patients with insomnia. Sleep Med. 2005;6(2):107-113. (Pubitemid 40247172)
47. Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel group, multicenter study. Sleep. 2008;31(1):79-90.
48. Lopez-Garcia E, van Dam RM, Willett WC, et al. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation. 2006;113(17):2045-2053.
49. Krakow B, Melendrez D, Ferreira E, et al. Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest. 2001;120(6):1923-1929. (Pubitemid 34053455)
50. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163(1):19-25. (Pubitemid 32095247)
51. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med. 2002;166(2):159-165. (Pubitemid 34765451)
52. Mills PJ, Dimsdale JE, Natarajan L, Ziegler MG, Maisel A, Greenberg BH. Sleep and health-related quality of life in heart failure. Congest Heart Fail. 2009;15(5):228-233.
53. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109 Suppl II:2-10.
54. Irwin MR, Wang M, Ribeiro D, et al. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry. 2008;64(6):538-540.
55. Burgos I, Richter L, Klein T, et al. Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav Immun. 2006;20(3):246-253.
56. Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part II: immunologic effects. J Clin Oncol. 2005;23(25):6097-6106.
57. Kang JE, Lim MM, Bateman RJ, et al. Amyloid-β dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005-1007.